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Abstract
Objectives Many family carers provide assistance with medicines that is vital for
optimal clinical outcomes.Medicines-related tasks are known to contribute to carer
burden and stress. This study examined the experiences of family carers when pro-
vidingmedicines-related assistance for a person with dementia, to indicate how ser-
vices could becomemore responsive to the specific needs of this group of carers.
Methods Semi-structured interviews were undertaken with family carers and care-
recipients identified though a memory clinic in north London and a local Alzhei-
mer’s Society. The interview guide, comprising open questions, was informed by
previous studies and consultation with stakeholders. Qualitative procedures involv-
ing a framework approach were employed in the analysis.
Key findings Fourteen interviews with carers and five with care-recipients were
conducted. These highlighted the burden and challenges, surrounding medicines-
management activities. As well as practical aspects that could be complex, carers
were commonly making judgements about the need for and appropriateness of
medicines. Although experiences were varied, carers reported difficulties in main-
taining supplies, ensuring adherence to regimens and accessing health professionals;
and they made some recommendations for service improvements. Carers’ difficulty
in obtaining information and advice about medicines was compounded by their
desire to allow the care-recipient to retain autonomy over their medicines as long as
possible.
Conclusion This study highlights the distinct needs and problems with regard to
medicines-management when caring for a person with dementia. As the prevalence
of dementia rises, interventions designed to address these specific aspects of reduce
carer-burden should be a priority for health professionals.
Introduction
The numbers of older people in the UK, as elsewhere, is
steadily rising with an increasing reliance on family carers. It
is estimated that 23%of theUK populationwill be older than
65 years in 2035, of which nearly a quarter will be over 85
years.[1] Incidence rates for dementia are also rising.Currently
in the UK there are an estimated 800 000 people with demen-
tia, by 2021 this is expected to increase to 1million.Over two-
thirds of people with dementia live in the community. They
are supported in their daily living by 670 000 family carers.[1]
With these demographic changes and the rising prevalence of
dementia, it is anticipated there will be a corresponding rise
in the numbers of, and dependence on, family carers.
The UK Government recognises the important role of
family carers and their contribution to health care,potentially
enabling older people to remain in their own homes for
longer.[2] The value of the support of family carers has been
estimated at £119 billion pa (significantly more than is spent
on the National Health Service (NHS)).[3] Support for family
carers has been identified by the UKDepartment of Health as
a policy priority, highlighting the need to improve informa-
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tion and support for family carers to enable them to be effec-
tive in their roles.[4,5] Many family carers are older people and
frail themselves.
Assistance with medicines is an integral part of the caring
role for many family carers.[3] Older people are major con-
sumers of medicines, and many receive vital assistance from
family carers in their use. The range of medicines-related
activities that carers can assume is wide,[6–8] ranging from
occasional assistance, e.g. collecting prescriptions from a
surgery or pharmacy, to regular attendance as necessitated by
frequent dosing regimens, assisting in the administration of
different dosage forms and/or advising on the need for, and
use of, various medicines. It is known that all medicines-
related activities can present problems for carers. Ensuring
that a person has a continuous supply of their medicines can
be a challenging task, e.g. different storage sites in the home,
pack sizes, formulations and variable need for medicines can
all contribute to these difficulties. Older people including
those with dementia are likely to have a number of
comorbidities requiring a range of differentmedicines.When
dosing regimens are frequent or complex, it can increase the
burden especially for carers who have competing demands
such as work commitments or children to look after. Prob-
lems and concerns are associated with all aspects of carers’
activities when assisting with medicines.[7,9–11]
When caring for a person with dementia, medicines-
related activities can become more complex. Family carers
may progressively assume greater responsibilities for all
aspects of medicines use Thus, the burden associated with
medicines-related activities will often increase. Assistance
required from carers will evolve as a consequence of limited
memory and understanding, possible lack of insight and
emergence of challenging behaviours. A recent study, in Aus-
tralia, found that carers of people with dementia had distinct
needs regarding medication management activities that con-
tributed to carer-burden and stress, often unacknowledged
by health professionals.[12] The UK Government in its
National Service Framework forOlder People (a policy docu-
ment for service development) acknowledged that at least
half of older people may not be taking their medicines as
intended and that older people and carers should be more
involved in therapy decisions and receive more information
on the risks and benefits.[13]
Supporting both care-recipients and carers can present
dilemmas for health professionals. There are often no formal
channels for imparting information to carers, as services are
mindful of preserving confidentiality and autonomy of care-
recipients. However, as disease progresses, ways in which
ongoing support for carers can be provided so they remain
effective in their roles need to be addressed. The provision of
care in the context of changing situations and needs of both
carers and care-recipients, and the operation of the partner-
ship between them will present challenges for health profes-
sionals.[14] The Royal College of General Practitioners has
highlighted the need for support for carers within health
service provision but acknowledged that ‘the best ideas are
still being conceptualised and that they will have to be evalu-
ated’.[15] They also recognise the importance of drawing on
carers’ experiences in informing the development of services.
The aims of this studywere to examine the scope and range
of medicines-related assistance provided by family carers of
people with dementia, the problems that arise and to identify
how service provision could becomemore responsive to these
needs.
Methods
This descriptive qualitative study was undertaken in collabo-
ration with the Barnet Memory Clinic (a National Health
Service clinic in the northern suburbs of London) and the
Barnet branch of theAlzheimer’s Society, a voluntary organi-
sation that supports carers and patients with memory prob-
lems. Data were collected in face-to-face semi-structured
interviews with carers and, when appropriate (able and
willing to consent) with care-recipients also.
Sampling and recruitment
Family carers of, and people with, dementia were recruited
through the memory treatment clinics at Barnet Hospital,
and the Barnet Branch of the Alzheimer’s Society. These two
sources enabled the involvement of carers of, and people
with, varying degrees of severity of disease as well as
people from a wide range of socio-economic and cultural
backgrounds.
Carers were eligible if they provided some assistance
(however minimal) with a medication for a person with a
diagnosis of dementia, were unpaid for the assistance they
provided, had at least weekly face-to-face contact with the
person they assisted and were the main (informal) carer. The
inclusion criteria for care-recipients were: a diagnosis of
dementia, living at home and able andwilling to consent. The
guidance of the Mental Capacity Act: Code of Practice for
researchers,[16] was followed whereby potential participants
were not excluded on the assumption of incapacity to consent
whilst always endeavouring to ensure a voluntary decision.
Letters of invitation (total 85), which included a digital
photo of the interviewer, separate information leaflets for
carers and care-recipients, and a reply slip were forwarded by
mail to potential participants identified by clinic staff and the
administrator of the Barnet Branch of the Alzheimer’s
Society. Carers and care-recipients who indicated their will-
ingness to participate, and were eligible, were contacted by
the researcher to arrange a time for a face-to-face interview at
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their homeor another location if preferred.Recruitment con-
tinued until data saturation (no new issues were emerging)
was achieved.
Data collection and instruments
The interview schedule for carers was a semi-structured
instrument to gather data onmedicines-related activities and
problems experienced by carers in assisting their care-
recipient with their medicines. The domains of the instru-
ment were based on a number of previous studies of carers
and medicines,[6–8] and in consultation with all members of
the research team (health professionals and representatives of
care-recipients and carers). Topics included monitoring sup-
plies in the home, liaising with health professionals (hospi-
tals, surgeries and pharmacies), reminders, assistance with
administration of different formulations, participating in
decisions about the need formedicines, doses and side effects.
Carers were asked about help provided and care-recipients
about the help that they received.While following this broad
framework, interviews were conducted according to princi-
ples of qualitative enquiry, and the use of open questions and
exploratory prompts to obtain participants’ own accounts,
examples of helpful practice or recommendations for service
improvements. Personal information was collected including
age, sex and relationship of carer to the care-recipient.
Informed consent from participants was obtained prior to
the commencement of any interview.With the permission of
participants, interviews were audio-recorded.
Data processing and analysis
All interviews were transcribed verbatim. A framework
approach to analysis was undertaken[17] involving the devel-
opment of an initial coding framework guided by responses
within each domain of the interview schedule. As analysis
proceeded, this was modified and refined using constant
comparison techniques, in which all items of data assigned a
particular code were appraised for similarities and diver-
gences from those already coded.Computer software (NVivo,
QSR International, Burlington, MA, USA) was used to assist
in the data management and handling. To ensure the reliabil-
ity of analytical procedures, all stages of the data processing,
coding and analysis involved two members of the research
team.
Ethical approval for the study from the NHS Research
Ethics Committee of Moorfields and Whittington, London,
was obtained prior to the commencement of the data study.
Results
The participants
A total of 14 interviews were conducted with carers. In five
cases, it was also possible to interview the care-recipient.
Fourteen (nine carers and five care-recipients) were con-
ducted at the homes of the participants. Four interviews with
carers were held in the clinic and one at a local coffee shop.All
participants agreed to audio-recording.
The 14 carers ranged from 45 to 86 years, and the five care-
recipients from 81 to 93 years. Eleven of the 14 carers and all
five care-recipients were women (see Table 1).
The carers included 10 daughters, two sons, one husband
and one wife. Five carers lived with the care-recipient. The
length of time that carers felt able to leave their care-recipient
alone provided an indication of severity of disease.Two carers
said they could leave them for much of the day and at night,
four could leave them for parts of the day, but not at night.
Two carers reported the care-recipient could only be left for a
couple of hours. The remaining six would not leave the care-
recipient alone.
The numbers of medicines taken by care-recipients ranged
from1 to15 (mean7). In addition tomedication for dementia
(usually donepezil), a wide range of medicines and formula-
tions were used for the management of concomitant condi-
tions, including cardiovascular disease, respiratory problems,
osteoporosis, joint pain andmental health problems.
Interviews with care-recipients
We included care-recipients in the study as we wished to
obtain their perspectives on the use of medicines and assis-
tance received. However, in many cases, it was difficult to
achieve much meaningful discussion, because of the severity
of disease. There were often discrepancies in the information
provided by care-recipients and carers, which when verified
in other parts of the interviews indicated the more limited
knowledge and understanding by the care-recipients.
Care-recipients’ responseswere generally brief.Only one of
the five care-recipients could comment on themedicines they
were taking. However, they all acknowledged that they
received assistance, which was generally valued and indicated
their carers should be adequately informed.
Wellmy family need to know all about it, they really do.
Because there is no point telling me, so they have to
know everything. (Care-recipient 4)
Interviews with family carers
The interviews with family carers provided detailed descrip-
tions of the scope of assistance provided and the problems
Table 1 Characteristics of participants
Participants Carers Care-recipients
Women 11 5
Men 3 0
Age-range 45–86 years (11 under 65
years)
81–93 years
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experienced. The results are presented according to the seven
themes that emerged in the analysis: ordering and collecting
from the surgery and/or pharmacy; dosage boxes, reminders
and administration; information about medicines; carers’
concerns about the effect of medicines; carers, care-recipients
and sharing of information; liaison with health professionals;
and suggestions for service developments.
Ordering and collecting from the surgery
and/or pharmacy
All carers assisted in ordering and/or collecting medicines
from the surgery and/or pharmacy, although the pharmacy
delivered in four cases. These activities were described in the
context of monitoring supplies and arranging timely refills.
. . . and so I monitor what medications she has and
hasn’t got left. And when we need more I ring through
to the medical practice and ask for a new prescription
and then collect them from the pharmacy. (Carer 8)
Most of the carers described the systems they put in place
to ensure continuous supplies which, although requiring
continual attention, often worked smoothly. However,
changes to prescription both added to carer-burden (by cre-
ating additional tasks) and stress for carers who wanted to be
sure that care-recipients were receiving the right medicines.
Themedication was delivered tomymumby the phar-
macy. But suddenly they stopped. . . . I live the other
side of London. They did not mention this earlier. So I
had to spend another day phoning around to get every-
thing done. I had come not to worry too much if she
missed a day of the ramipril or aspirin, because these
pills were more preventative. But I didn’t want her to
miss theAricept [donepezil].After that Iwrote down in
my agendawhen to get a newprescription.But it would
be so much easier if things would go automatically.
(Carer 4)
Monitoring supplies and making timely orders could be a
complex task, especially if prescriptions were obtained from
more than one source (e.g. hospital clinic and general practi-
tioner (GP)), there were differing ordering procedures,
and/or varying lengths of supply for different medicines.
Dosage boxes, reminders and administration
Six carers filled dosage boxes (placing tablets in compart-
ments for each day of the week and time of day). In one case a
pharmacist did this. For some carers, a dosage boxwas helpful
and reduced carers’ concerns regarding whether the right
medicines were being taken.
I make a dosage box every week with all her medicines
in, so it is easier to take them, and we are sure she takes
the right ones. (Carer 1)
Dosage boxes were also an additional task for carers,
increasing the burden of caring and associated anxieties
regarding the potential for errors:
There was one day that the agency suddenly phoned up
and told me all my mother’s pills will have to be in a
dosage box. And that had to happen in 48 h, otherwise
theywould stop giving her the pills.Theywere trying to
protect their carers and I understand that, but they
could have givennotice a bit earlier. So I had to rush out
and buy a little plastic box and move all the pills that
the chemist was supplying. And I was as afraid as the
carers to make a mistake. It meant I had to make this
box every week. (Carer 4)
However, carersmay prefer to take responsibility and know
that prescriptions were correct:
I don’t want the pharmacist to make the box, because
they change quite often themedications of mywife, it is
much easier for me to make the box. (Carer 5)
Ensuring that care-recipients took their medicines on time
was important to many carers. Thirteen (of the 14) carers
gave reminders to take medicines. For carers who did not live
with the care-recipient, thismight be timely phone calls,but it
sometimes necessitated regular and frequent visits.
Every afternoon after my work, I go to my mother’s
house and make sure she takes her medicines and the
same thing when she goes to bed. Last 4 years, I’ve not
been away. It’s impossible, she needsmy help. (Carer 1)
Missed doses as a consequence of reluctance on the part of
the care-recipient to take medication, difficulties swallowing
or poor memory could be a concern for carers:
Some days he just refused to take them.That happened
almost weekly and then we were not able to give the
medicines because he did not want to take them.
Though sometimes he took them when you waited for
a little time. (Carer 2)
She thinks she doesn’t need them. . . It’s a shame that
she can’t remember why she was told to take them.
(Carer 9)
Information about medicines
Many carers were proactive in seeking out information about
medicines. They described reading package information,
researching on the Internet, magazines, telephone calls to a
doctor and two carers had access to a BNF. For some carers,
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doctors (GP or memory clinic) were the principal source of
information, although insufficient time in consultations to
ask questions was also a concern. Information about what, or
howmuch, to take andpotential side effectswere identified by
carers as the most important issues.
Particularly with any newmedication, carers wanted infor-
mation on potential side-effects. Seeking this information
was often the impetus for research on the Internet or advice
from others. Package inserts were important sources, but
interpretation of information and making judgements pre-
sented difficulties:
When she lived alone and had to take her blood pres-
sure tablets onher own and I came in the afternoon, the
tablet was still in the dosage box and I didn’t know
what to do. I did not know if it could hurt her to give
the tablet at that moment or if I had to wait until the
next morning. (Carer 1)
Carers concerns about the effect of medicines
Carers were also watchful regarding the effectiveness and in
particular potential side effects of medication, often making
judgements on the appropriateness of therapy and/or inter-
vening when deemed necessary:
. . . when he was taking Aricept it had not the right
effect on him and it made him worse in his behaviour.
Carer 2)
. . . I was reading the digoxin leaflet lately and it says
that on the things digoxin does is confusion and Mum
is taking a really high dose of digoxin, sowe don’t know
if we stop that, that will improve her memory. (Carer
12)
She feels terribly tired all the time. I’m not sure if this is
a side-effect of the newmedicine. (Carer 5)
Carers, care-recipients and sharing information
Many carers endeavoured to share informationwith the care-
recipient and wanted to support their involvement in deci-
sions about their medicines. However, also, care-recipients
wishing to remain autonomous over their medicines was
problematic for some carers:
It is really difficult. Mum. . . forgets. What I’ve done is
sort of sit down and explain things, and her own family
doctor has tried to explain things. I wantMum to know
what is going on. She is very independent. (Carer 11)
I used to give her information, but now she forgets all.
(Carer 3)
..my mother won’t let me [be involved in decisions]
because she wants to be independent. (Carer 10)
Because carers might not be present in a consultation, they
were often not informed of medication and regimens pre-
scribed. This was especially difficult when there were any
changes to a prescription.
. . . it is wise to invite a member of the family so
if that person forgets there is someone else,
hopefully, to remember what information is given.
(Carer 8)
the doctor doubled the dosage without even telling us,
we only found it out by collecting the tablets at the
pharmacy. (Carer 12)
Liaison with health professionals: support
for carers
Many carers described positive experiences regarding the
support they received from health professionals, especially in
the clinics they attended. However, problems were experi-
enced in contacting health professionals, especially on behalf
of care-recipients, and in particular in accessing the care-
recipient’s GP:
I have no good contact with my mother’s GP. I cannot
reach her normally, only by receptionist or by post. I
would prefer to contact by phone or email, but for a
strange reason that is not possible. And I really want to
discuss some things with her. . . Carers should be
involved always and as much as possible. Because they
are the ones who will remember the information.
(Carer 3)
However, when carers were present, they sometimes
described how the consultation may then exclude the care-
recipient. As discussed above, carers endeavoured to share
information with care-recipients; they also believed care-
recipients should be involved in discussions:
. . . and sometimes the doctor is talking tome aboutmy
dad when he is sitting next to me, but they should talk
to him because he can answer the questions better than
I can. I think they have to know he is not that bad.
(Carer 7)
Our GP was talking only to me as if she was not
there. My mother thought he was saying she was
mad because he was not talking to her. I was so angry.
(Carer 6)
. . . they should attend the discussion as everybody else.
They will forget it afterwards but I think it is insulting
not to talk to the patients. (Carer 8)
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Suggestions by carers for
service developments
A number of suggestions were made by carers for service
developments. These related to the provision of information;
access to, and communication with, GPs; and pharmacy ser-
vices (see Table 2).
Discussion
The findings of this study illustrate the essential help with
medicines that family carers of people with dementia provide
and confirms how medicines-related activities are a con-
spicuous and potentially stressful part of the caring role.
This study was limited in that it involved just a small
number of carers from one part of London. Although the
needs and perspectives of family carers in assisting with
medicines may be replicated elsewhere, differences, e.g. in
service provision,may affect carers’ experiences.
Making sure care-recipients received the rightmedicines at
the right time was a priority for carers. Carers described how
they had to understand regimens and ordering procedures,
and take responsibility for monitoring requirements. The
continual checking required could be burdensome andwhen,
inadvertently supplies were low, securing continuous sup-
plies could be stressful. Carers also made their own assess-
ments regarding the suitability of medicines with regard to
perceived benefits and (potential or actual) adverse effects. In
these tasks, carers often did not feel adequately informed or
experienced difficulties in interpreting and applying medi-
cines information. They described difficulties in accessing
health professionals for advice, which might assist them in
making these judgements.
Carers’ problems in assisting these care-recipients with
medicines could also be compounded by a lack of under-
standing and challenging behaviours of the person they
were assisting. Sometimes differing views of carers and
care-recipients regarding the need for medicines could
present dilemmas for carers, who despite witnessing symp-
toms of disease progression, generally wished to encourage
patient autonomy in decisions regarding the use of medi-
cines. Carers were generally strong advocates of patient
autonomy and worked in their best interests. Accordingly,
care-recipients interviewed in this study, though limited in
the perspectives they could provide, acknowledged their
dependence on their carers.
Carers’ experiences of communication and support from
health professionals was hugely variable. While some carers
identified key health professionals and clinic staff who were
understanding and helpful, some carers identified areas to be
addressed. Carers were keen for care-recipients to be
informed, involved in decisions and to retain control over
their medicines as much as possible. However, consultations
that focus on a care-recipient’s needs should also address
those of carers.
Some carers also expressed dissatisfaction with the balance
and focus of consultations involving a health professional,
patient and carer. This might be insufficient attention to the
perspectives of either the care-recipient or the carer. As
disease progresses many carers, while wanting the care-
recipient to remain central, were frustrated at the difficulties
of ensuring their need for information and concerns were
addressed.To ensure that carers are able to perform their roles
effectively, there is a balance to be achieved between preserv-
ing care-recipient’s autonomy and independence while
ensuring a process inwhich carers are involved, informed and
supported in their roles.
Carers also experienced difficulties in being able to contact
health professionals themselves for information.While some
consultations were helpful, outside these, formal channels of
communication for carers were not described. Issues of con-
fidentiality and patient autonomy may present barriers. A
particular problem for carers was that they would not
Table 2 Suggestions by carers for service developments
Information
• Provision of information in the second consultation: avoiding too much at initial diagnosis but ensuring it provided at any early stage.
• Providing information about what medicines are for, side effects, what to look out for
• Routine communication of important information to the carer, as well as the care-recipient, especially if the carer cannot be at consultation, e.g.
when medicines or regimens are changed.
GPs: access and communication
• GPs to be more accessible for carers, e.g. recognition by surgery staff of role of carers and being prepared to talk to them.
• Timing of consultations that accommodate carer’s competing commitments, especially for carers who work
• Clear and accessible systems for contact by telephone or e-mail
• More training for GPs in communicating with people with memory problems
• Simplified systems for ordering prescriptions, e.g. computers that recognise when new prescription is due.
Pharmacists and potential roles
• Pharmacists could assist in ensuring medicines refills are timely
• Pharmacists can be good source of advice, but consistency between pharmacies in quality of services needs to be addressed.
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necessarily be informed of changes to prescriptions or regi-
mens. This difficulty has been identified in other studies[9,12]
and reflects poor systems for communication between
primary and secondary care in the UK as well as with family
carers.[13,18]
While other studies have identified medication-related
roles of family carers,[6–8] assisting a person with dementia
presents additional issues that need to be taken into account
in designing services.[15] However, many older people will
have many differing needs and some who do not have a diag-
nosis of dementiamay experiencememory problems thatwill
have implications for carers. Carers in this study made a
number of practical suggestions: improved processes and
practices regarding communication with GPs, systems to
improve transfer and timing of medicines-related informa-
tion; and possible roles of pharmacy services in assisting in
timely refills and information about medicines. In recent
years there have been initiatives in theUK, to support optimal
use of medicines by care-recipients living in their ownhomes.
These include Medicines Use Review, a widely used service
delivered by community pharmacists[19] for which there i6s
some evidence that they have a positive effect on adherence,
medicines use and clinical outcomes although more research
is required to be certain of these effects.[20] However, at
present, these do not formally include and separately address
the needs family carers.
The study highlights the need for the provision of training
and support for family carers that cover a wide range of
factors, including specific attention to medication. The
Barnet Alzheimer’s Society, who collaborated in this study,
now have an information and support officer whose role
could include such interventions.
However, the development of interventions to reduce asso-
ciated carer-burden and enable carers to be effective needs to
be a priority for health professionals, and in their evaluation,
carer-burden associated with medicines-management activ-
ities is an important outcomemeasure. Instruments currently
available[21] do not specifically address the added dimensions
and challenges of caring for a person with dementia. The
activities, problems and needs of carers as identified in this
study could provide a starting point for the development of a
relevant and sensitive outcomemeasure.
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